Blatter; Fritz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blatter; Fritz.The latest application filed is for "crystalline forms of pitavastatin calcium".

Company Profile

11.56.96

Blatter; Fritz - Reinach CH
Blatter; Fritz - Basel CH
Blatter; Fritz - US
Blatter; Fritz - Reinach BL DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid Grant 11,377,448 - Moser , et al. July 5, 2	2022-07-05
Crystalline Forms Of Pitavastatin Calcium App 20220169614 - VAN DER SCHAAF; Paul Adriaan ; et al.	2022-06-02
Crystalline Sodium Salt Of 5-methyl-(6s)-tetrahydrolic Acid App 20220016121 - MOSER; Rudolf ; et al.	2022-01-20
Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid Grant 11,185,545 - Moser , et al. November 30, 2	2021-11-30
Ferroportin-inhibitor salts Grant 11,129,820 - Morris , et al. September 28, 2	2021-09-28
Crystalline Salts Of 5-methyl-(6s)-tetrahydrofolic Acid And L-leucine Ethyl Ester App 20210283136 - MOSER; Rudolf ; et al.	2021-09-16
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester App 20210275533 - MOSER; Rudolf ; et al.	2021-09-09
Crystalline Salts Of 5-methyl-(6s)-tetrahydrofolic Acid And Amino Ethyl Esters App 20210277006 - MOSER; Rudolf ; et al.	2021-09-09
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester App 20210269444 - MOSER; Rudolf ; et al.	2021-09-02
Crystalline Salt Comprising 5-methyl-(6s)-tetrahydrofolic Acid And 4-(2-hydroxyethyl)-morpholine App 20210220366 - MOSER; Rudolf ; et al.	2021-07-22
Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases Grant 11,066,408 - Moser , et al. July 20, 2	2021-07-20
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide maleate Grant 11,059,829 - Blatter , et al. July 13, 2	2021-07-13
Crystalline Sodium Salt Of 5-methyl-(6s)-tetrahydrofolic Acid App 20210107902 - MOSER; Rudolf ; et al.	2021-04-15
Crystalline Forms Of Pitavastatin Calcium App 20210002227 - VAN DER SCHAAF; Paul Adriaan ; et al.	2021-01-07
Pharmaceutical Compound, Salts Thereof, Formulations Thereof, And Methods Of Making And Using Same App 20200361933 - Nagapudi; Karthik ; et al.	2020-11-19
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1- -yl)-N-(pyridin-2-yl)benzamide malea App 20200255437 - Kind Code	2020-08-13
Crystalline Forms Of Pitavastatin Calcium App 20200148644 - VAN DER SCHAAF; Paul Adriaan ; et al.	2020-05-14
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma Grant 10,640,509 - Blatter , et al.	2020-05-05
Ferroportin-Inhibitor Salts App 20200113885 - Morris; Collin D. ; et al.	2020-04-16
Crystalline Binary Sodium Salts Of 5-methyl-(6s)-tetrahydrofolic Acid With Organic Bases App 20200039982 - MOSER; Rudolf ; et al.	2020-02-06
Crystalline Sodium Salt Of 5-methyl-(6s)-tetrahydrolic Acid App 20200030333 - MOSER; Rudolf ; et al.	2020-01-30
Solid Forms and Formulations of Imidazopyrazine Compound App 20190337949 - Blatter; Fritz ; et al.	2019-11-07
Crystalline Forms Of Pitavastatin Calcium App 20190256469 - Van Der Schaaf; Paul Adriaan ; et al.	2019-08-22
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide Grant 10,167,291 - Blatter , et al. J	2019-01-01
Crystalline Forms Of Pitavastatin Calcium App 20180346425 - Van Der Schaaf; Paul Adriaan ; et al.	2018-12-06
Methods And Compositions For The Treatment Of Metabolic Disorders App 20180256582 - Oppenheimer; Daniel I. ; et al.	2018-09-13
Multicomponent Crystals Of Dasatinib With Menthol Or Vanillin App 20180230140 - VIERTELHAUS; Martin ; et al.	2018-08-16
Solid form of abiraterone acetate Grant 10,045,998 - Chiodo , et al. August 14, 2	2018-08-14
Solid Forms and Formulations of Imidazopyrazine Compound App 20180208596 - Blatter; Fritz ; et al.	2018-07-26
Methods and compositions for the treatment of metabolic disorders Grant 9,993,481 - Oppenheimer , et al. June 12, 2	2018-06-12
Salts of dasatinib in amorphous form Grant 9,884,857 - Hafner , et al. February 6, 2	2018-02-06
Crystalline Forms Of Pitavastatin Calcium App 20180029987 - VAN DER SCHAAF; Paul Adriaan ; et al.	2018-02-01
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide Grant 9,796,721 - Blatter , et al. October 24, 2	2017-10-24
Multicomponent crystalline system comprising nilotinib and selected co-crystal formers Grant 9,567,317 - Chiodo , et al. February 14, 2	2017-02-14
Solid Forms and Formulations of Imidazopyrazine Compound App 20170029428 - Blatter; Fritz ; et al.	2017-02-02
Salts of Dasatinib in crystalline form Grant 9,556,164 - Hafner , et al. January 31, 2	2017-01-31
Crystalline Forms Of Pitavastatin Calcium App 20170022163 - VAN DER SCHAAF; Paul Adriaan ; et al.	2017-01-26
Methods And Compositions For The Treatment Of Metabolic Disorders App 20160367558 - Oppenheimer; Daniel I. ; et al.	2016-12-22
Solid Form Of Abiraterone Acetate App 20160303143 - CHIODO; Tiziana ; et al.	2016-10-20
Methods and compositions for the treatment of metabolic disorders Grant 9,433,624 - Oppenheimer , et al. September 6, 2	2016-09-06
Crystalline dapagliflozin hydrate Grant 9,394,328 - Blatter , et al. July 19, 2	2016-07-19
Salts Of Dasatinib In Amorphous Form App 20160168142 - HAFNER; Andreas ; et al.	2016-06-16
Salts Of Dasatinib In Crystalline Form App 20160168143 - HAFNER; Andreas ; et al.	2016-06-16
Multicomponent crystals comprising dasatinib and selected co-crystal formers Grant 9,340,536 - Chiodo , et al. May 17, 2	2016-05-17
Crystalline asenapine hydrochloride salt forms Grant 9,303,036 - Blatter , et al. April 5, 2	2016-04-05
Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof Grant 9,290,452 - Hafner , et al. March 22, 2	2016-03-22
Multicomponent system of rosuvastatin calcium salt and sorbitol Grant 9,249,108 - Hafner , et al. February 2, 2	2016-02-02
Crystalline Forms Of Pitavastatin Calcium App 20160024010 - VAN DER SCHAAF; Paul Adriaan ; et al.	2016-01-28
Crystalline salts of Asenapine with organic di-acids and tri-acids Grant 9,169,262 - Blatter , et al. October 27, 2	2015-10-27
Multicomponent Crystalline System Comprising Nilotinib And Selected Co-crystal Formers App 20150246901 - Chiodo; Tiziana ; et al.	2015-09-03
Multicomponent Crystalline System Comprising Deferasirox And Isonicotinamide And A Process For The Preparation Thereof App 20150175544 - Hafner; Andreas ; et al.	2015-06-25
Multicomponent Crystals Comprising Dasatinib And Selected Co-crystal Formers App 20150133463 - Chiodo; Tiziana ; et al.	2015-05-14
Multicomponent Crystalline System Of Voriconazole With Fumaric Acid App 20150087657 - Hafner; Andreas ; et al.	2015-03-26
Crystalline compound of 7-[(3R)-3-amino-1-oxo-4-(2, 4, 5-trifluorophenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluoromethyl)-1, 2, 4 -triazolo[4,3-A]pyrazin Grant 8,916,559 - Blatter , et al. December 23, 2	2014-12-23
Crystalline Forms Of Pitavastatin Calcium App 20140364614 - VAN DER SCHAAF; Paul Adriaan ; et al.	2014-12-11
Crystalline Dapagliflozin Hydrate App 20140323417 - Blatter; Fritz ; et al.	2014-10-30
Crystalline forms of pitavastatin calcium Grant 8,853,405 - Van Der Schaaf , et al. October 7, 2	2014-10-07
Multicomponent crystalline system of rosuvastatin calcium salt and vanillin Grant 8,841,316 - Hafner , et al. September 23, 2	2014-09-23
Multicomponent Crystalline System Of Rosuvastatin Calcium Salt And Vanillin App 20140194453 - HAFNER; Andreas ; et al.	2014-07-10
Novel Crystalline Salts Of Asenapine App 20140163083 - Blatter; Fritz ; et al.	2014-06-12
Multicomponent Crystalline System Of Ezetimibe And Proline App 20140155371 - Hafner; Andreas ; et al.	2014-06-05
Crystalline Sodium Salt Of An Hiv Integrase Inhibitor App 20140135353 - Blatter; Fritz ; et al.	2014-05-15
Novel Crystalline Salts Of Asenapine With Organic Di-acids And Tri-acids App 20140128444 - Blatter; Fritz ; et al.	2014-05-08
Multicomponent crystalline system of rosuvastatin calcium salt and vanillin Grant 8,716,305 - Hafner , et al. May 6, 2	2014-05-06
Novel Crystalline Asenapine Hydrochloride Salt Forms App 20140121259 - Blatter; Fritz ; et al.	2014-05-01
Multicomponent Crystalline System Of Rosuvastatin Calcium Salt And Vanillin App 20140031377 - Hafner; Andreas ; et al.	2014-01-30
Crystalline Forms Of Pitavastatin Calcium App 20140005402 - VAN DER SCHAAF; Paul Adriaan ; et al.	2014-01-02
Crystalline forms of pitavastatin calcium Grant 8,557,993 - Van der Schaaf , et al. October 15, 2	2013-10-15
5,6-D hydro-1H-pyridin-2-one compounds Grant 8,546,602 - Tran , et al. October 1, 2	2013-10-01
Multicomponent System Of Resuvastatin Calcium Salt And Sorbitol App 20130237553 - Hafner; Andreas ; et al.	2013-09-12
Macrolide synthesis process and solid-state forms Grant 8,518,900 - Warrass , et al. August 27, 2	2013-08-27
Macrolide synthesis process and solid-state forms Grant 8,461,121 - Warrass , et al. June 11, 2	2013-06-11
Crystalline Forms Of Pitavastatin Calcium App 20130053413 - Van der Schaaf; Paul Adriaan ; et al.	2013-02-28
Process for preparing crystalline polymorphic forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride Grant 8,344,139 - Moser , et al. January 1, 2	2013-01-01
5,6-dihydro-1h-pyridin-2-one Compounds App 20120302744 - Tran; Chinh V. ; et al.	2012-11-29
Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride Grant 8,318,745 - Moser , et al. November 27, 2	2012-11-27
Macrolide Synthesis Process And Solid-state Forms App 20120208779 - Blatter; Fritz ; et al.	2012-08-16
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms Grant 8,236,960 - Thygesen , et al. August 7, 2	2012-08-07
Macrolide synthesis process and solid-state forms Grant 8,227,429 - Warrass , et al. July 24, 2	2012-07-24
Crystalline Compound Of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri Fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazin App 20120142693 - Blatter; Fritz ; et al.	2012-06-07
Macrolide Synthesis Process And Solid-state Forms App 20120122808 - Warrass; Ralf ; et al.	2012-05-17
Methods And Compositions For The Treatment Of Metabolic Disorders App 20120108599 - Oppenheimer; Daniel I. ; et al.	2012-05-03
Crystalline Forms Of Pitavastatin Calcium App 20120101126 - Van Der Schaaf; Paul Adriaan ; et al.	2012-04-26
5,6-dihydro-1H-pyridin-2-one compounds Grant 8,101,800 - Tran , et al. January 24, 2	2012-01-24
Methods and compositions for the treatment of metabolic disorders Grant 8,067,416 - Oppenheimer , et al. November 29, 2	2011-11-29
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its Tartrate Salt and Crystalline Forms App 20110184179 - THYGESEN; Mikkel Boas ; et al.	2011-07-28
5,6-dihydro-1h-pyridin-2-one Compounds App 20110166344 - Tran; Chinh V. ; et al.	2011-07-07
Crystalline forms of rosuvastatin calcium salt Grant 7,932,387 - Blatter , et al. April 26, 2	2011-04-26
P-toluene sulfonic acid salt of 5-amino-3-(2'-O-acetyl-3'-deoxy-.beta.-D-ribofuranosyl)-3H-thiazole[4,5-d- ]pyrimidine-2-one and methods for preparation Grant 7,928,085 - Kucera , et al. April 19, 2	2011-04-19
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms Grant 7,923,564 - Thygesen , et al. April 12, 2	2011-04-12
Macrolide synthesis process and solid-state forms App 20110053875 - Blatter; Fritz ; et al.	2011-03-03
Process for the parallel detection of crystalline forms of molecular solids Grant 7,892,354 - Blatter , et al. February 22, 2	2011-02-22
Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N'-(4-(2-methylprop- yloxy)phenylmethyl)carbamide and their preparation Grant 7,868,176 - Thygesen , et al. January 11, 2	2011-01-11
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its Tartrate Salt and Crystalline Forms App 20100305329 - THYGESEN; Mikkel Boas ; et al.	2010-12-02
Crystalline Forms Of Dmxaa Sodium Salt App 20100286254 - Blatter; Fritz ; et al.	2010-11-11
Crystalline Forms Of (6r)-l-erythro-tetrahydrobiopterin Dihydrochloride App 20100240667 - Moser; Rudolf ; et al.	2010-09-23
Crystalline forms of Rizatriptan benzoate Grant 7,777,049 - Van Der Schaaf , et al. August 17, 2	2010-08-17
N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phe- nylmethyl)carbamide and its tartrate salt and crystalline forms Grant 7,732,615 - Thygesen , et al. June 8, 2	2010-06-08
Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride Grant 7,727,987 - Moser , et al. June 1, 2	2010-06-01
Crystalline Forms Of (6r)-l-erythro-tetrahydrobiopterin Dihydrochloride App 20100099685 - MOSER; Rudolf ; et al.	2010-04-22
5,6-dihydro-1h-pyridin-2-one Compounds App 20100034773 - Tran; Chinh V. ; et al.	2010-02-11
Methods And Compositions For The Treatment Of Metabolic Disorders App 20100009996 - Oppenheimer; Daniel I. ; et al.	2010-01-14
Crystalline forms of atorvastatin App 20090281162 - Schaaf; Paul Adriaan Van Der ; et al.	2009-11-12
P-Toluene Sulfonic Acid Salt of 5-Amino-3-(2'-O-Acetyl-3'-Deoxy-Beta-D-Ribofuranosyl)-3H-Thiazole[4,5-d]p- yrimidine-2-one and Methods for Preparation App 20090197826 - Kucera; David ; et al.	2009-08-06
Methods and compositions for the treatment of metabolic disorders Grant 7,566,714 - Oppenheimer , et al. July 28, 2	2009-07-28
Crystalline Forms Of Pitavastatin Calcium App 20090182008 - VAN DER SCHAAF; Paul Adriaan ; et al.	2009-07-16
Crystalline forms of atorvastatin Grant 7,538,136 - Van Der Schaaf , et al. May 26, 2	2009-05-26
Sealing system with flow channels Grant 7,504,071 - Blatter , et al. March 17, 2	2009-03-17
Macrolide Synthesis Process and Solid-State Forms App 20090042815 - Blatter; Fritz ; et al.	2009-02-12
Crystalline form App 20080269315 - Blatter; Fritz ; et al.	2008-10-30
Crystalline Forms of Rizatriptan Benzoate App 20080249149 - Van Der Schaaf; Paul Adriaan ; et al.	2008-10-09
Crystalline form of Fluvastatin sodium Grant 7,432,380 - Van Der Schaaf , et al. October 7, 2	2008-10-07
Crystalline Forms Of Rosuvastatin Calcium Salt App 20080194604 - Blatter; Fritz ; et al.	2008-08-14
Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists Grant 7,402,587 - Briand , et al. July 22, 2	2008-07-22
Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists App 20070173520 - Briand; Thierry ; et al.	2007-07-26
Crystalline forms of zolmitriptan App 20070173536 - Van Der Schaaf; Paul Adriaan ; et al.	2007-07-26
Process for the parallel detection of crystalline forms of molecular solids App 20070134803 - Blatter; Fritz ; et al.	2007-06-14
Crystalline form of fluvastatin sodium App 20060241167 - Van Der Schaaf; Paul Adriaan ; et al.	2006-10-26
Crystalline forms of atorvastatin App 20060205805 - Van Der Schaaf; Paul Adriaan ; et al.	2006-09-14
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and crystalline forms App 20060205780 - Thygesen; Mikkel Boas ; et al.	2006-09-14
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and crystalline forms App 20060205781 - Thygesen; Mikkel Boas ; et al.	2006-09-14
Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof App 20060205714 - Tolf; Bo-Ragnar ; et al.	2006-09-14
Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof App 20060199808 - Tolf; Bo-Ragnar ; et al.	2006-09-07
Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide and new crystal forms thereof App 20060142566 - Mathes; Christian ; et al.	2006-06-29
Crystalline forms of pitavastatin calcium App 20060142582 - Van Der Schaaf; Paul Adriaan ; et al.	2006-06-29
Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylprop- yloxy)phenylmethyl)carbamide and their preparation App 20060111399 - Thygesen; Mikkel Boas ; et al.	2006-05-25
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and crystalline forms App 20060106063 - Thygesen; Mikkel Boas ; et al.	2006-05-18
Crystalline forms of ( 6R)-L-erythro-tetrahydrobiopterin dihydrochloride App 20060035900 - Moser; Rudolf ; et al.	2006-02-16
Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof App 20050282800 - Tolf, Bo-Ragnar ; et al.	2005-12-22
Crystalline polymorphic and amorphous forms of benazepril hydrochloride App 20050107359 - Van Der Schaaf, Paul Adriaan ; et al.	2005-05-19
Sealing system with flow channels App 20040239044 - Blatter, Fritz ; et al.	2004-12-02
Crystalline forms of atorvastatin App 20040220255 - Schaaf, Paul Adriaan Van Der ; et al.	2004-11-04
Crystalline form App 20040106670 - Blatter, Fritz ; et al.	2004-06-03
Crystalline forms of cerivastatin sodium App 20040063961 - Van Der Schaaf, Paul Adriaan ; et al.	2004-04-01
Agrochemical composition App 20040038824 - Haesslin, Hans Walter ; et al.	2004-02-26
Crystalline forms of atorvastatin App 20030114686 - Van Der Schaaf, Paul Adriaan ; et al.	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.